Table 6.
Details of participants that developed SSI
| Gender | Study group | Body site | Modified MMS* |
Surgical repair | Other complications | Organism isolated on swab MC&S | Sensitivity to cephalexin |
| Male | Control | Ear | No | Graft | Nil | Staphylococcus aureus | Yes |
| Male | Control | Ear | No | Graft | Nil | S. aureus | Yes |
| Male | Control | Nose | No | Flap | Nil | Hafnia alvei | No |
| Male | Control | Ear | No | Flap | Nil | S. aureus | Yes |
| Male | Control | Ear | No | Flap | Nil | S. aureus | Yes |
| Male | Control | Nose | No | Flap | Nil | S. aureus | Yes |
| Male | Control | Nose | No | Flap | Nil | GP without swab | Unknown |
| Female | Control | Nose | No | Flap | Nil | S. aureus | Yes |
| Female | Intervention | Ear | No | Flap | Nil | Pseudomonas aeruginosa | No |
*Delayed surgical closure awaiting complete histological margin analysis.
GP, general practitioner; MC&S, Microscopy, Culture and Sensitivity; MMS, Mohs micrographic surgery; SSI, surgical site infection.